×
About 1,173 results

ALLMedicine™ Brachytherapy Center

Research & Reviews  458 results

Completion surgery after intensity-modulated arc therapy for locally advanced cervical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993655
World Journal of Surgical Oncology; Van Damme A, Rombaut J et. al.

Mar 8th, 2023 - Chemoradiotherapy (CRT) followed by brachytherapy (BT) is the standard treatment for locally advanced cervical cancer (LACC), but replacement of BT by surgery (CRT-S) could be an acceptable alternative. The main concern is the risk of operative mo...

Quality of life in patients who underwent robot-assisted radical prostatectomy compared...
https://doi.org/10.1002/pros.24507
The Prostate; Nakai Y, Tanaka N et. al.

Mar 7th, 2023 - To compare the quality of life (QOL) in patients who underwent robot-assisted radical prostatectomy (RARP) or low-dose-rate brachytherapy (LDR-BT) for prostate cancer. We enrolled patients who underwent LDR-BT (LDR-BT alone [n = 540] or LDR-BT plu...

The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy f...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990264
Radiation Oncology (London, England); Song S, Han D et. al.

Mar 7th, 2023 - This study retrospectively compared the clinical and toxicity outcomes for the cervical cancer of the MRI-guided two adaptive brachytherapy (IGABT) fractions versus one IGABT fraction in one application. One hundred and twenty patients with cervic...

Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dos...
https://doi.org/10.1007/s10147-023-02314-0
International Journal of Clinical Oncology; Imai Y, Urabe F et. al.

Feb 23rd, 2023 - Although brachytherapy is a standard treatment option for patients with high-risk prostate cancer, only a few studies have compared low-dose-rate brachytherapy (LDR-BT) and high-dose-rate brachytherapy (HDR-BT). We applied propensity score-based i...

Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision.
https://doi.org/10.1016/j.clon.2023.01.021
Clinical Oncology (Royal College of Radiologists (Great B... Fionda B, Pagliara MM et. al.

Feb 16th, 2023 - Uveal melanoma represents the most common intraocular neoplasia among adults. Brachytherapy (interventional radiotherapy; IRT) has a great advantage, when compared with enucleation, both in terms of organ and function sparing. The Collaborative Oc...

see more →

News  11 results

Radiation Therapy, Brachytherapy Outcomes Similar for Localized Prostate Cancer
https://www.medscape.com/viewarticle/938756

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

Radiation Therapy, Brachytherapy Outcomes Similar for Localized Prostate Cancer
https://www.staging.medscape.com/viewarticle/938756

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

In High-Risk Endometrial Cancer, Adding Chemo No Help, but…
https://www.staging.medscape.com/viewarticle/886383

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

In High-Risk Endometrial Cancer, Adding Chemo No Help, but…
https://www.medscape.com/viewarticle/886383

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?
https://www.medscape.com/viewarticle/852435

Oct 16th, 2015 - Hello. I am Dr Gerald Chodak for Medscape. Today, I want to talk about high-dose-rate temporary brachytherapy (HDRTB) for men with high-risk prostate cancer. I came across an article on Prostate Cancer Infolink that cited three randomized trials r...

see more →